Genomic and Proteomic Analysis of Disease Progression in Idiopathic Pulmonary Fibrosis (IPF)
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Kevin F Gibson, MD
University of Pittsburgh - Dorothy P. and Richard P. Simmons Center for Interstitial Lung Disease
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Michelle F Macpherson
Pittsburgh, Pennsylvania, United States
Daniel J. Kass, M.D.Daniel Sullivan, MDEleanor Valenzi, MDGillian Goobie, MD PhDJohn Sembrat, PhDKevin F Gibson, MDKristen Veraldi, M.D.Luis Ortiz, MDMichelle F. MacPherson, BS, MATMichelle Meyers, BSN, RNMorgan L Carnahan, BSPrabhir Ray, PhDSeyed Mehdi Nouraie, MDTimothy Corcoran, PhDXiaoping Chen, MSXiaoyun Li, MDYingze Zhang, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2005
- Primary completion
- 31 Jul 2030
- Completion
- 31 Jul 2030
- Last update posted
- 29 Oct 2025
- Registered enrollment
- 500
- Registry id
- NCT00373841
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.